Striatal dopamine nerve terminal markers but not nigral cellularity are reduced in spinocerebellar ataxia type 1

Neurology

Volumn 48, Issue 4, 1997, Pages 1109-1111

  Kish, S J ^a   Guttman, M ^a   Robitaille, Y ^b   El Awar, M ^c   Chang, L J ^a   Levey, A I ^d  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CAUDATE NUCLEUS; CELL LOSS; CEREBELLAR ATAXIA; DOPAMINE UPTAKE; DOPAMINERGIC NERVE CELL; ENZYME SYNTHESIS; HUMAN; HUMAN TISSUE; NERVE DEGENERATION; NERVE ENDING; NEUROTRANSMITTER RELEASE; PARKINSONISM; PRIORITY JOURNAL; PUTAMEN;

EID: 0030897669     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.4.1109     Document Type: Article

References (10)

1. Kish SJ, Robitaille Y, El-Awar M, et al. Striatal monoamine neurotransmitters and metabolites in dominantly-inherited olivopontocerebellar atrophy. Neurology 1992;42:1573-1577.
2. Zhong X-H, Haycock JW, Shannak K, et al. Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy. Mov Disord 1995;10:10-17.
3. Orr HT, Chung M-Y, Banfi S, et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet 1993;4:221-226.
4. Wilson JM, Levey Al, Rajput A, et al. Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease. Neurology 1996;47:718-726.
5. Kawaguchi Y, Okamoto T, Taniwaki M, et al. CAG expansions in a novel gene from Machado-Joseph disease at chromosome 14q32.1 Nat Genet 1994;8:221-227.
6. Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. N Engl J Med 1988;318:867-880.
7. 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration. J Neurosci 1994;14:2966-2979.
8. Robitaille Y, Schut L, Kish SJ. Structural and immunocytochemical features of SCA-1-linked olivopontocerebellar atrophy define a unique phenotype. Acta Neuropathol (Berl) 1995; 90:572-581.
9. Ciliax BJ, Heilman C, Demchyshyn LL, et al. The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci 1995;15:1714-1723.
10. Wilson JM, Carroll ME, Kish SJ. The vesicular monoamine transporter, in contrast to the dopamine transporter, is not regulated following chronic cocaine self-administration. J Neurosci 1996;16:3507-3510.